Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MSANTD3-TMEFF1 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-08 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | SLX4 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-08 |
mRNA | MSH2 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
mRNA | WDR24 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
mRNA | CTD-2192J16.17 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-08 |
mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | PPP1R3E | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |